Early detection

is key

LungLife AI is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence.

One in 16 people in the US will be diagnosed with lung cancer in their lifetime—and in many cases when it’s too late. We believe our simple blood test may afford those at risk a much better outcome through early diagnosis.”

Paul Pagano | CEO, LungLife AI

Our core purpose
is simple

To Be a Driving Force

behind a significant rise in the early detection of this pernicious cancer.

To achieve our purpose, we are

dedicated to working collaboratively

 with scientific and clinical partners.

Our LungLB® Test

is a blood-based tool that has been developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer, and is now ready for validation studies. We have a CLIA certified laboratory in Thousand Oaks, California. Our objective is to have our test FDA approved.

Learn more about

LUNG CANCER

Featured News

October 1, 2020

LungLife AI, with Collaborators from Mount Sinai and MD Anderson, to Present Clinical Data on Liquid Biopsy Test for Early Lung Cancer Detection

THOUSAND OAKS, CA – October 1, 2020 – LungLife AI, a leader in liquid biopsy technology for cancer diagnosis and management, announced today that clinical data from a research collaboration in early lung cancer detection will be presented at the International Association for the Study of Lung Cancer (IASLC) Hot Topic Meeting taking place on October 2nd […]
• Read More
December 23, 2019

LungLife AI Receives CLIA certification for its Cancer Diagnostic Laboratory

LungLife AI, the developer of an Artificial Intelligence (AI) enabled non-invasive liquid biopsy test for the early detection of lung cancer, announced today that the Company has received certification from the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Under the “deemed status” provision of the US Department of Health and Human Services (HHS) Center for […]
• Read More
1 2 3
© 2021 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.
crossmenu